Sign in

CIK 0001849296 · Non-accelerated filer<br>Emerging growth company

OKYO Pharma Ltd

Sign in to watch
Ticker
OKYO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Entity type
other
Phone
44 (0) 207 495 2379
Business address
55 PARK LANE, LONDON, United Kingdom, W1K 1NA
  1. 6-K Event Report of Foreign Issuer
  2. 6-K Event Report of Foreign Issuer
  3. 6-K Event Report of Foreign Issuer
  4. 6-K Event Report of Foreign Issuer
  5. 6-K Event Report of Foreign Issuer
  6. 6-K Event Report of Foreign Issuer
  7. 20-F/A Report Annual and Transition Report of Foreign Private Issuers
  8. 4/A Open-market buy Director bought 5,000 shares at $1.48 ($7,385)
  9. 4/A Open-market buy CHIEF EXECUTIVE OFFICER bought 15,000 shares at $1.54 ($23,085)
  10. 4/A Open-market buy CHIEF DEVELOPMENT OFFICER bought 3,500 shares at $1.40 ($4,900)
  11. 4/A Open-market buy Director bought 22,500 shares at $1.45 ($32,625)
  12. 4/A Open-market buy Director bought 25,000 shares at $1.40 ($35,000)
  13. 4/A Open-market buy CHIEF MEDICAL OFFICER bought 20,000 shares at $1.40 ($28,000)
  14. 4/A Open-market buy Chief Scientific Officer bought 3,363 shares at $1.49 ($5,011)
  15. 4 Grant or award Chief Scientific Officer acquired 3,363 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 6-K Event Report of Foreign Issuer
  18. 6-K Event Report of Foreign Issuer
  19. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 15,000 shares (grant or award)
  20. 4 Grant or award Director acquired 22,500 shares (grant or award)

Page 1 of 16 · 312 filings